Hank Dorkin ’70 holds two roles at Children’s Hospital of Boston. He serves as both the director of the Cystic Fibrosis Center and associate chief of the division of respiratory diseases. Under Dorkin’s direction, patients of the Cystic Fibrosis Center continue to fare in the top 10 to 20 percent of the country for a variety of health parameters including lung function and nutritional status.
After graduating from Lehigh in 1970, Dorkin attended the Johns Hopkins University School of Medicine. Dorkin completed his residency and became a Parker B. Francis Research Fellow in Pulmonary Disease and Cystic Fibrosis at Harvard Medical School and Children's Hospital.
Following his time at Children’s Hospital, Dorkin was asked to form the Pediatric Pulmonary Unit at the Tufts University Medical School and the New England Medical Center's Floating Hospital for Children. He also served as an ICU Attending and Director of the Cystic Fibrosis Center at the Floating Hospital. While there, Dorkin performed the first inhalational gene therapy trial in Cystic Fibrosis patients in the world.Dorkin also served as professor of pediatrics until 2002 when he joined the Massachusetts General Hospital and Harvard Medical School as Director of the Joey O'Donnell Cystic Fibrosis Center and Co-Director of the CF Therapeutic Development Research Program. In that role, Dorkin helped develop a number of new therapies for Cystic Fibrosis. Dorkin has also served as an associate professor of pediatrics at Harvard Medical School.